Myeloperoxidase deficiency preserves vasomotor function in humans

European Heart Journal

Volumn 33, Issue 13, 2012, Pages 1625-1634

  Rudolph, Tanja K ^a   Wipper, Sabine ^a   Reiter, Beate ^a   Rudolph, Volker ^a   Coym, Anja ^a   Detter, Christian ^a   Lau, Denise ^a   Klinke, Anna ^a   Friedrichs, Kai ^a   Rau, Thomas ^b   Pekarova, Michaela ^c   Russ, Detlef ^d   Knöll, Kay ^e   Kolk, Mandy ^e   Schroeder, Bernd ^e   Wegscheider, Karl ^b   Andresen, Hilke ^b   Schwedhelm, Edzard ^b   Boeger, Rainer ^b   Ehmke, Heimo ^b   Baldus, Stephan ^a   more..

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c INSTITUTE OF BIOPHYSICS   (Czech Republic)

^d Institute for Lasertechnology   (Germany)

^e UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Endothelium; Leucocyte; Myeloperoxidase; Nitric oxide; Vascular tone

Indexed keywords

ALBUMIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCERYL TRINITRATE; MYELOPEROXIDASE; NICOTINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME DEFICIENCY; EX VIVO STUDY; FEMALE; HEART LEFT ATRIUM; HEART MUSCLE PERFUSION; HUMAN; INTERNAL MAMMARY ARTERY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEUKOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE; VASOMOTOR DISORDER; VASOMOTOR REFLEX;

ADULT; AGED; ANIMALS; BLOOD FLOW VELOCITY; CORONARY CIRCULATION; ENDOTHELIUM, VASCULAR; HEMODYNAMICS; HUMANS; MALE; MAMMARY ARTERIES; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; NICOTINE; NITRIC OXIDE; PEROXIDASE; SUS SCROFA; VASODILATION; VASOMOTOR SYSTEM; YOUNG ADULT;

EID: 84863656464     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr193     Document Type: Article

References (33)

1. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 2005;77:598-625. (Pubitemid 40628741)
2. Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994;94:437-444. (Pubitemid 24218123)
3. Baldus S, Heitzer T, Eiserich JP, Lau D, Mollnau H, Ortak M, Petri S, Goldmann B, Duchstein HJ, Berger J, Helmchen U, Freeman BA, Meinertz T, Münzel T. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med 2004;37:902-911. (Pubitemid 39078559)
4. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 2001;158:879-891. (Pubitemid 32221781)
5. Baldus S, Eiserich JP, Mani A, Castro L, Figueroa M, Chumley P, MaW, Tousson A, White CR, Bullard DC, Brennan ML, Lusis AJ, Moore KP, Freeman BA. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 2001;108:1759-1770. (Pubitemid 34015121)
6. Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, Schmitt D, Fu X, Thomson L, Fox PL, Ischiropoulos H, Smith JD, Kinter M, Hazen SL. Apolipoprotein AI is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 2004; 114:529.
7. Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Hörkkö S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 2007;13:1176-1184. (Pubitemid 47530630)
8. Rudolph V, Andrié RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B, Schwoerer AP, Lau D, Fu X, Klingel K, Sydow K, Didié M, Seniuk A, von Leitner EC, Szoecs K, Schrickel JW, Treede H, Wenzel U, Lewalter T, Nickenig G, Zimmermann WH, Meinertz T, Böger RH, Reichenspurner H, Freeman BA, Eschenhagen T, Ehmke H, Hazen SL, Willems S, Baldus S. Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 2010;16: 470-474.
9. Askari AT, Brennan ML, Zhou X, Drinko J, Morehead A, Thomas JD, Topol EJ, Hazen SL, Penn MS. Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med 2003;197:615-624. (Pubitemid 36314656)
10. Moncada S, Higgs EA. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest 1991;21:361-374.
11. Ignarro LJ. Endothelium-derived nitric oxide: actions and properties. The FASEB J 1989;3:31-36. (Pubitemid 19042562)
12. Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, Castro L, Lusis AJ, Nauseef WM, White CR, Freeman BA. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002;296:2391-2394. (Pubitemid 34734213)
13. Abu-Soud HM, Hazen SL. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem 2000;275:37524-37532. (Pubitemid 32004861)
14. Kutter D. Prevalence of myeloperoxidase deficiency: population studies using Bayer-Technicon automated hematology. J Mol Med 1998;76:669-675. (Pubitemid 28412744)
15. Iho S, Tanaka Y, Takauji R, Kobayashi C, Muramatsu I, Iwasaki H, Nakamura K, Sasaki Y, Nakao K, Takahashi T. Nicotine induces human neutrophils to produce IL-8 through the generation of peroxynitrite and subsequent activation of NF-kappaB. J Leukoc Biol 2003;74:942-951. (Pubitemid 38040371)
16. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R, International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flowmediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-265. (Pubitemid 34084631)
17. Tsikas D, Gutzki FM, Rossa S, Bauer H, Neumann C, Dockendorff K, Sandmann J, Frölich JC. Measurement of nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry and by the Griess assay: problems with the Griess assay-solutions by gas chromatography-mass spectrometry. Anal Biochem 1997;244:208-220. (Pubitemid 27043316)
18. Eiserich JP, Cross CE, Jones AD, Halliwell B, van der Vliet A. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J Biol Chem 1996;271: 19199-19208. (Pubitemid 26271585)
19. Detter C, Wipper S, Russ D, Iffland A, Burdorf L, Thein E, Wegscheider K, Reichenspurner H, Reichart B. Fluorescent cardiac imaging: a novel intraoperative method for quantitative assessment of myocardial perfusion during graded coronary artery stenosis. Circulation 2007;116:1007-1014. (Pubitemid 47329565)
20. Glenny RW, Bernard S, Brinkley M. Validation of fluorescent-labeled microspheres for measurement of regional organ perfusion. J Appl Physiol 1993;74: 2585-2597. (Pubitemid 23157092)
21. Vita JA, Brennan ML, Gokce N, Mann SA, Goormastic M, Shishehbor MH, Penn MS, Keaney JF, Hazen SL. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 2004;110:1134-1139. (Pubitemid 39319014)
22. Baldus S, Rudolph V, Roiss M, Ito WD, Rudolph TK, Eiserich JP, Sydow K, Lau D, Szöcs K, Klinke A, Kubala L, Berglund L, Schrepfer S, Deuse T, Haddad M, Risius T, Klemm H, Reichenspurner HC, Meinertz T, Heitzer T. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 2006;113:1871-1878. (Pubitemid 43739399)
23. Kayal S, Jäs JP, Aguini N, Chaudière J, Labrousse J. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 1998;157:776-784.
24. Tang WH, Brennan ML, Philip K, TongW, Mann S, Van Lente F, Hazen SL. Plasma myeloperoxidase levels in patients with chronic heart failure. Am J Cardiol 2006; 98:796-799. (Pubitemid 44301017)
25. Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003;349: 1595-1604. (Pubitemid 37288567)
26. Ingram RH, Szidon JP, Skalak R, Fishman AP. Effects of sympathetic nerve stimulation on the pulmonary arterial tree of the isolated lobe perfused in situ. Circ Res 1968;22:801-815.
27. Downing SE, Lee JC. Nervous control of the pulmonary circulation. Ann Rev Physiol 1980;42:199-210. (Pubitemid 10081246)
28. Grover RF, Wagner WW, McMurty IF, Reeves JT. Handbook of Physiology. Bethesda, MD: American Physiological Society; 1983. p103-135.
29. Zhang C, Patel R, Eiserich JP, Zhou F, Kelpke S, MaW, Parks DA, Darley-Usmar V, White CR. Endothelial dysfunction is induced by proinflammatory oxidant hypochlorous acid. Am J Physiol Heart Circ Physiol 2001;281:H1469-H1475.
30. Zhang C, Reiter C, Eiserich JP, Boersma B, Parks DA, Beckman JS, Barnes S, Kirk M, Baldus S, Darley-Usmar VM, White CR. L-arginine chlorination products inhibit endothelial nitric oxide production. J Biol Chem 2001;276:27159-27165.
31. Kutter D, Devaquet P, Vanderstocken G, Paulus JM, Marchal V, Gothot A. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit?. Acta Haematol 2000;104:10-15.
32. Wong ND, Gransar H, Narula J, Shaw L, Moon JH, Miranda-Peats R, Rozanski A, Hayes SW, Thomson LE, Friedman JD, Berman DS. Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events. JACC Cardiovasc Imaging 2009;2: 1093-1099.
33. Meuwese MC, Stroes ES, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007;50:159-165. (Pubitemid 47002189)